You are a helpful, respectful, and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information.
What is A patient with leprosy had slightly erythematous, anesthetic plagues on the trunk and upper limbs. He was treated with paucibacillary multidrug therapy (PB-MDT) for 6 months. At the end of 6 months, he had persistent erythema and induration in the plaque. The next step of action recommended by the WOrld Health Organization (WHO) in such a patient is - and explain in detail?
<p> Stop antileprosy treatment. According to WHO treatment guidelines for leprosy -all MB patients who have completed 12 or more doses of WHO MDT for Multibacillary leprosy &;should be regarded as cured&; and removed from the registers. It is not necessary to give MDT to PB patients until clinical inactivity . In a large number of patients it is not possible to clinical inactivity in six months even though all organisms are killed. Reference:Park&;s textbook of preventive and social medicine,K.Park,21st e pg no.299,22nd edition,page no:298 and WHO website.. <\p>